This trial will study the effects of a Physician Orders for Scope of Treatment (POST) Facilitation in a population of older adults who qualify for it, including those with normal cognition and those with Alzheimer's Disease and related disorders.
1 Primary · 7 Secondary · Reporting Duration: Assessed 12 months from the date that the patient receives POST facilitation or home safety evaluation
Experimental Treatment
876 Total Participants · 1 Treatment Group
Primary Treatment: POST Facilitation · No Placebo Group · N/A
Age 65+ · All Participants · 10 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:Indiana | 100.0% |
Eskenazi Health | 50.0% |
IU Health Methodist Hospital | 50.0% |
Met criteria | 100.0% |
3+ | 100.0% |
100.0% | |